Back to all papers

Multichannel Deep Learning Radiomics for Predicting Chemoimmunotherapy Response in Gastric Cancer: Multicenter Validation and Chemotherapy-alone Specificity Assessment.

November 16, 2026pubmed logopapers

Authors

Ran C,Wang C,Chu G,Kong D

Affiliations (4)

  • Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Tianjin Key Laboratory of Digestive Cancer, Tianjin, China (C.R.). Electronic address: [email protected].
  • Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China (C.W.). Electronic address: [email protected].
  • Department of Radiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China (C.W.). Electronic address: [email protected].
  • Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China (D.K.). Electronic address: [email protected].

Abstract

To develop and validate a computed tomography-based model integrating multichannel deep learning and radiomics for predicting pathologic significant response (PSR) to neoadjuvant chemoimmunotherapy (NACI) in locally advanced gastric cancer (LAGC), and to assess whether the model specifically captures immunotherapy-related phenotypes by testing it on a chemotherapy-alone cohort. This multicenter study included 455 patients with LAGC: 411 receiving NACI (split into training, internal validation, and external test set 1) and 44 receiving chemotherapy alone (test set 2). From three-dimensional (3D) segmentations, the largest axial, coronal, and sagittal slices were stacked as three-channel input for a pretrained ResNet50 to extract deep features; radiomic features were extracted from the 3D volume. Features were fused, reduced by the least absolute shrinkage and selection operator, and modeled with a support vector machine to construct a deep learning radiomics (DLR) signature. A combined model further incorporated mismatch repair status, programmed death-ligand 1 combined positive score, and tumor grade. Model performance was evaluated by area under the curve (AUC), calibration, and decision curve analysis, with SHAP for interpretability. The multichannel model outperformed single-plane models (AUCs: 0.783, 0.749, 0.706). The DLR model achieved the highest AUCs (0.827, 0.802, 0.776), surpassing radiomics-only (0.756, 0.712, 0.691) and multichannel deep models. Critically, its AUC dropped to 0.597 in the chemotherapy-alone cohort. SHAP provided global and individual feature attributions. The multichannel DLR model accurately predicts PSR to NACI in LAGC. The substantial performance decline in the chemotherapy-alone cohort suggests that the captured imaging phenotypes may be more closely associated with immunotherapy-related response, rather than with general chemosensitivity, potentially offering a noninvasive, interpretable tool for pretreatment stratification.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.